<DOC>
	<DOCNO>NCT01005368</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue patient cancer laboratory may help doctor identify learn biomarkers related cancer . PURPOSE : This research study look biomarkers blood bone marrow sample patient previously untreated chronic lymphocytic leukemia .</brief_summary>
	<brief_title>Study Biomarkers Blood Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Determine relevance common uncommon interphase cytogenetic abnormality relate baseline clinical feature , complete response ( CR ) , prolong progression-free survival ( PFS ) , overall survival ( OS ) patient previously untreated chronic lymphocytic leukemia . - Determine significance absence IgV_H gene mutational status relate ability predict CR , PFS , OS patient . - Correlate IgV_H gene mutational status CD38 expression , ZAP-70 expression , over-expression Mcl-1 , BAK-1 , high Mcl-1 : Bax ratio , p53 mutation dysfunction , high-risk karyotype abnormality , molecular feature associate poor outcome patient . - Determine prognostic significance over-expression Mcl-1 , BAK-1 , high Mcl-1 : Bax ratio , p53 mutation dysfunction , ATM mutation , ATM expression , factor disrupt apoptosis respect CR , prolong PFS , OS . - Determine clonal evolution occur biological marker partial response disease relapse . OUTLINE : This multicenter study . Blood bone marrow collect baseline , 3 month completion induction therapy , 2 month completion consolidation therapy , 1 year completion study treatment , disease relapse . Samples analyze FISH interphase cytogenetics , PCR IgV_H mutational status , flow cytometry surface expression CD38 cell , western blot ass Mcl-1 , Bcl-2 , BAK-1 , ATM , ZAP-70 , Bar expression , sequence p53 ATM function .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis chronic lymphocytic leukemia Previously untreated disease Registered receive treatment Cancer Leukemia Group B protocol PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>chronic lymphocytic leukemia</keyword>
</DOC>